Carine Kolly

1.1k total citations
17 papers, 390 citations indexed

About

Carine Kolly is a scholar working on Cell Biology, Molecular Biology and Pharmacology. According to data from OpenAlex, Carine Kolly has authored 17 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cell Biology, 5 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Carine Kolly's work include Skin and Cellular Biology Research (4 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Carine Kolly is often cited by papers focused on Skin and Cellular Biology Research (4 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Carine Kolly collaborates with scholars based in Switzerland, United States and Germany. Carine Kolly's co-authors include Eliane J. Müller, Maja M. Suter, Lina Williamson, S. Martinod, Ulf Neumann, Laura H. Jacobson, Donna F. Kusewitt, Irena Brzak, Ludovic Perrot and Susanne Müller and has published in prestigious journals such as Scientific Reports, FEBS Letters and Infection and Immunity.

In The Last Decade

Carine Kolly

17 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carine Kolly Switzerland 8 153 87 61 52 50 17 390
Céline Borlon Belgium 12 184 1.2× 50 0.6× 134 2.2× 132 2.5× 9 0.2× 16 597
Musharraf Jelani Pakistan 17 401 2.6× 228 2.6× 49 0.8× 25 0.5× 22 0.4× 53 643
Li Yu China 11 245 1.6× 40 0.5× 42 0.7× 41 0.8× 15 0.3× 50 599
Fred Tsen United States 8 440 2.9× 101 1.2× 32 0.5× 93 1.8× 8 0.2× 9 589
Ke‐Ping Xu United States 9 282 1.8× 85 1.0× 33 0.5× 137 2.6× 10 0.2× 10 849
Yiu‐Kay Lai Taiwan 11 233 1.5× 79 0.9× 28 0.5× 40 0.8× 8 0.2× 21 394
Jimmy Larsson Sweden 14 323 2.1× 98 1.1× 20 0.3× 26 0.5× 11 0.2× 19 575
Stefanie De Schepper Belgium 14 296 1.9× 25 0.3× 28 0.5× 42 0.8× 45 0.9× 25 553
Eri Nishioka Japan 10 258 1.7× 166 1.9× 38 0.6× 200 3.8× 11 0.2× 18 680
Théodora Niault Austria 8 431 2.8× 243 2.8× 12 0.2× 47 0.9× 28 0.6× 9 696

Countries citing papers authored by Carine Kolly

Since Specialization
Citations

This map shows the geographic impact of Carine Kolly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carine Kolly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carine Kolly more than expected).

Fields of papers citing papers by Carine Kolly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carine Kolly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carine Kolly. The network helps show where Carine Kolly may publish in the future.

Co-authorship network of co-authors of Carine Kolly

This figure shows the co-authorship network connecting the top 25 collaborators of Carine Kolly. A scholar is included among the top collaborators of Carine Kolly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carine Kolly. Carine Kolly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hewitt, Philip, Andreas Hartmann, Belén Tornesi, et al.. (2024). Importance of tailored non-clinical safety testing of novel antimalarial drugs: Industry best-practice. Regulatory Toxicology and Pharmacology. 154. 105736–105736. 2 indexed citations
3.
Vormfelde, Stefan Viktor, Nicole Pezous, Gilbert Lefèvre, et al.. (2020). A Pooled Analysis of Three Randomized Phase I/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by Umibecestat. Clinical and Translational Science. 13(6). 1316–1326. 6 indexed citations
4.
Graf, Ana, Carine Kolly, Valérie Dubost, et al.. (2019). FTS3‐01‐01: UMIBECESTAT (CNP520) IS NOT ASSOCIATED WITH CHANGES IN HIPPOCAMPAL MORPHOLOGY IN RATS OR CHANGES IN CSF AD BIOMARKERS IN HUMANS TREATED FOR 3 MONTHS. Alzheimer s & Dementia. 15(7S_Part_17). 2 indexed citations
5.
Pognan, François, Maria Papoutsi, David Ledieu, et al.. (2018). Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and human. Archives of Toxicology. 92(5). 1877–1891. 3 indexed citations
6.
Beckmann, Nicolau, Arno Doelemeyer, Stefan Zurbruegg, et al.. (2016). Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor–treated APP transgenic mice. Neurobiology of Aging. 45. 50–60. 14 indexed citations
7.
Shimshek, Derya R., Laura H. Jacobson, Carine Kolly, et al.. (2016). Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice. Scientific Reports. 6(1). 21917–21917. 49 indexed citations
8.
Neumann, Ulf, Laura H. Jacobson, Karen Beltz, et al.. (2016). P1‐083: Preclinical Pharmacology of Bace Inhibitor CNP520. Alzheimer s & Dementia. 12(7S_Part_9). 1 indexed citations
9.
Mecklenburg, Lars, Donna F. Kusewitt, Carine Kolly, et al.. (2013). Proliferative and Non-Proliferative Lesions of the Rat and Mouse Integument. Journal of Toxicologic Pathology. 26(3_Suppl). 27S–57S. 40 indexed citations
10.
Müller, Eliane J., Lina Williamson, Carine Kolly, & Maja M. Suter. (2008). Outside-in Signaling through Integrins and Cadherins: A Central Mechanism to Control Epidermal Growth and Differentiation?. Journal of Investigative Dermatology. 128(3). 501–516. 126 indexed citations
12.
Müller, Eliane J., Reto Caldelari, Carine Kolly, et al.. (2006). Consequences of Depleted SERCA2-Gated Calcium Stores in the Skin. Journal of Investigative Dermatology. 126(4). 721–731. 20 indexed citations
13.
Kolly, Carine, Maja M. Suter, & Eliane J. Müller. (2005). Proliferation, Cell Cycle Exit, and Onset of Terminal Differentiation in Cultured Keratinocytes: Pre-Programmed Pathways in Control of C-Myc and Notch1 Prevail Over Extracellular Calcium Signals. Journal of Investigative Dermatology. 124(5). 1014–1025. 69 indexed citations
14.
Kolly, Carine, et al.. (2004). Cardiac Rhabdomyoma in a Juvenile Fallow Deer (Dama dama). Journal of Wildlife Diseases. 40(3). 603–606. 6 indexed citations
15.
Kolly, Carine, et al.. (1990). Prophylactic effects of recombinant bovine interferon -αI1 on acute Salmonella typhimurium infection in calves. American Journal of Veterinary Research. 51(7). 1095–1099. 7 indexed citations
16.
Kolly, Carine, et al.. (1990). Prophylactic effects of recombinant bovine interferon-alpha I1 on acute Salmonella typhimurium infection in calves.. PubMed. 51(7). 1095–9. 7 indexed citations
17.
Kolly, Carine, et al.. (1990). Induction of circulating tumor necrosis factor cannot be demonstrated during septicemic salmonellosis in calves. Infection and Immunity. 58(2). 439–442. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026